SCHEMBL5812677

SCHEMBL5812677

CCOC(=O)N1CCC(c2nc(-c3ccccc3F)c(-c3ccnc(NC4CCCC4)n3)s2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 4/20 0.48
CDK1 P06493 3/20 0.48
CDK4 P11802 3/20 0.48
CCND1 P24385 3/20 0.48
DGAT1 O75907 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NOS2 P35228 4/20 0.44
MAPK14 Q16539 1/20 0.43
NR1I2 O75469 1/20 0.43
MAPK8 P45983 2/20 0.42
MAPK9 P45984 2/20 0.42
MAPK10 P53779 1/20 0.42
TP53 P04637 1/20 0.41
NOS1 P29475 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5818416 0.99 CDK2 (0.47) CDK2CDK1CDK4CCND1DGAT1
SCHEMBL5817915 0.97 CDK2 (0.51) CDK2CDK1CDK4CCND1DGAT1
SCHEMBL5819594 0.87 EGFR (0.52) EGFRKCNH2
SCHEMBL5814694 0.87 DGAT1 (0.48) CDK2CDK1CDK4CCND1DGAT1
SCHEMBL5819187 0.86 EGFR (0.53) EGFRKCNH2
SCHEMBL5818194 0.86 DGAT1 (0.48) CDK2CDK1CDK4CCND1DGAT1
SCHEMBL5817835 0.86 ALDH1A1 (0.43) KDM4EMEN1ALDH1A1GAAMAPK1
SCHEMBL5814889 0.86 EGFR (0.45) KDM4EMEN1ALDH1A1GAAMAPK1
SCHEMBL5813737 0.85 KCNH2 (0.49) MAPK8MAPK9EGFRKCNH2
SCHEMBL5819853 0.85 DGAT1 (0.49) CDK2CDK1CDK4CCND1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed